Mylan Laboratories Ltd. - Research Center
524794 MATRIXLAB Group (B) BSE data
Results
Statement
More
| Mar ' 10 |
Mar ' 09 |
Mar ' 08 |
Mar ' 07 |
Mar ' 06 |
Equity share capital
| 31.27 |
30.92 |
30.92 |
30.82 |
30.73 |
Share application money
Preference share capital
Reserves & surplus
| 1,120.92 |
838.40 |
648.99 |
947.71 |
838.70 |
Secured loans
| 450.29 |
448.85 |
403.82 |
223.08 |
151.54 |
Unsecured loans
| 161.61 |
198.96 |
39.58 |
3.94 |
4.25 |
Total
| 1,764.09 |
1,525.41 |
1,131.30 |
1,205.56 |
1,025.22 |
Gross block
| 1,130.44 |
832.30 |
655.67 |
583.88 |
478.92 |
Less : revaluation reserve
Less : accumulated depreciation
| 272.13 |
219.10 |
180.01 |
146.43 |
117.38 |
Net block
| 858.31 |
613.20 |
475.67 |
437.46 |
361.54 |
Capital work-in-progress
| 133.41 |
147.51 |
114.92 |
24.78 |
55.67 |
Investments
| 176.66 |
231.90 |
231.90 |
507.40 |
344.04 |
Current assets, loans & advances
| 1,315.52 |
988.04 |
738.43 |
631.54 |
647.73 |
Less : current liabilities & provisions
| 719.80 |
455.23 |
429.61 |
395.62 |
383.76 |
Total net current assets
| 595.71 |
532.81 |
308.82 |
235.92 |
263.97 |
Miscellaneous expenses not written
Total
| 1,764.09 |
1,525.41 |
1,131.30 |
1,205.56 |
1,025.22 |
Book value of unquoted investments
| 176.66 |
231.90 |
231.90 |
507.40 |
344.04 |
Market value of quoted investments
Contingent liabilities
| 129.60 |
169.22 |
205.23 |
1,084.72 |
964.78 |
Number of equity sharesoutstanding (Lacs)
| 1563.39 |
1546.14 |
1545.79 |
1541.08 |
1536.17 |